Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA approves label update to Novo Nordisk’s Tresiba diabetes drug
FDA approves label update to Novo Nordisk’s Tresiba diabetes drug
FDA approves label update to Novo Nordisk’s Tresiba diabetes drug
Submitted by
admin
on March 26, 2018 - 10:39pm
Source:
Drug Delivery Business News
News Tags:
FDA
Novo Nordisk
diabetes
Tresiba
labeling
insulin degludec
Headline:
FDA approves label update to Novo Nordisk’s Tresiba diabetes drug
Do Not Allow Advertisers to Use My Personal information
